Evidence map›Paper›PMID 39054288›Full record

ArticleLife science alliance2024

Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas.

Robert M Bragg, Ella W Mathews, Andrea Grindeland, Jeffrey P Cantle, David Howland, Tom Vogt, Jeffrey B Carroll

Abstract read
In one paragraph

Article in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert M BraggDepartment of Psychology, Western Washington University, Bellingham, WA, USA.ORCID 0000-0003-0619-8954
Ella W MathewsDepartment of Psychology, Western Washington University, Bellingham, WA, USA.ORCID 0000-0003-1183-1988
Andrea GrindelandMcLaughlin Research Institute, Great Falls, MT, USA.
Jeffrey P CantleDepartment of Psychology, Western Washington University, Bellingham, WA, USA.
David HowlandCHDI Foundation, Princeton, NJ, USA.
Tom VogtCHDI Foundation, Princeton, NJ, USA.
Jeffrey B CarrollDepartment of Psychology, Western Washington University, Bellingham, WA, USA jeffcarr@uw.edu.ORCID 0000-0003-1711-8868

Funding

Modulation of Exosome Release for Functional Restoration in Age-related Retinal DisordersP20GM152335 · NIGMS · MC LAUGHLIN RESEARCH INSTITUTE · PI Renee A Reijo Pera · 2024 to 2026
$11.1M
NIGMS NIH HHS P20 GM152335
6 · The paper itself

Abstract

Huntington's disease (HD) is a fatal neurodegenerative disorder caused by an expanded CAG tract in the huntingtin (HTT) gene, leading to toxic gains of function. HTT-lowering treatments are in clinical trials, but the risks imposed are unclear. Recent studies have reported on the consequences of widespread HTT loss in mice, where one group described early HTT loss leading to fatal pancreatitis, but later loss as benign. Another group reported no pancreatitis but found widespread neurological phenotypes including subcortical calcification. To better understand the liabilities of widespread HTT loss, we knocked out

Indexed as

Disease Models, AnimalHuntingtin ProteinHuntington DiseaseMice, KnockoutPancreasAnimalsCalcinosisFemaleMaleMiceNeurodegenerative DiseasesPhenotypeHtt protein, mouseHuntingtin Protein

Identifiers

PMID39054288
PMCPMC11272958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.